中华内科杂志
中華內科雜誌
중화내과잡지
CHINESE JOURNAL OF INTERNAL MEDICINE
2011年
3期
193-196
,共4页
孙慧%叶静%廖张元%李存江%尤小凡%李坤成%刘亚欧%段云云
孫慧%葉靜%廖張元%李存江%尤小凡%李坤成%劉亞歐%段雲雲
손혜%협정%료장원%리존강%우소범%리곤성%류아구%단운운
视神经脊髓炎%脑损害%磁共振成像
視神經脊髓炎%腦損害%磁共振成像
시신경척수염%뇌손해%자공진성상
Neuromyelitis optica%Brain damage%Magnetic resonance imaging
目的 探讨视神经脊髓炎(NMO)脑部损害临床和影像学特征以及血清NMO-IgG和NMO脑损害之间的关系.方法 收集37例NMO患者临床资料,1.5T超导型MR扫描仪获取患者头颅及脊髓MRI图像,细胞免疫荧光方法检测血清NMO-IgG.结果 17例患者头颅MRI上发现异常信号;病灶主要位于大脑白质,侧脑室、中脑导水管和胼胝体周围及桥脑、延髓,根据病灶形态可将其分为散在不规则型(13/17例)、融合型(3/17例)、多发性硬化样(1/17例),以散在不规则型病灶多见;5例伴有脑干病变者主要临床表现为:嗜睡、呕吐、复视、视物旋转,其他脑白质区损害无临床症状,11例脑损害患者血清NMO-IgG抗体阳性.结论 约半数NMO伴有脑损害,病灶多分布于大脑白质、脑室旁、脑干等水通道蛋白4(AQP4)高表达区,临床表现与病灶大小无关而与病灶部位有关:脑干受累者易伴有相应临床表现,大脑白质病变无临床表现.血清NMO-IgG抗体检测有助于鉴别伴有脑病灶的NMO和多发性硬化.
目的 探討視神經脊髓炎(NMO)腦部損害臨床和影像學特徵以及血清NMO-IgG和NMO腦損害之間的關繫.方法 收集37例NMO患者臨床資料,1.5T超導型MR掃描儀穫取患者頭顱及脊髓MRI圖像,細胞免疫熒光方法檢測血清NMO-IgG.結果 17例患者頭顱MRI上髮現異常信號;病竈主要位于大腦白質,側腦室、中腦導水管和胼胝體週圍及橋腦、延髓,根據病竈形態可將其分為散在不規則型(13/17例)、融閤型(3/17例)、多髮性硬化樣(1/17例),以散在不規則型病竈多見;5例伴有腦榦病變者主要臨床錶現為:嗜睡、嘔吐、複視、視物鏇轉,其他腦白質區損害無臨床癥狀,11例腦損害患者血清NMO-IgG抗體暘性.結論 約半數NMO伴有腦損害,病竈多分佈于大腦白質、腦室徬、腦榦等水通道蛋白4(AQP4)高錶達區,臨床錶現與病竈大小無關而與病竈部位有關:腦榦受纍者易伴有相應臨床錶現,大腦白質病變無臨床錶現.血清NMO-IgG抗體檢測有助于鑒彆伴有腦病竈的NMO和多髮性硬化.
목적 탐토시신경척수염(NMO)뇌부손해림상화영상학특정이급혈청NMO-IgG화NMO뇌손해지간적관계.방법 수집37례NMO환자림상자료,1.5T초도형MR소묘의획취환자두로급척수MRI도상,세포면역형광방법검측혈청NMO-IgG.결과 17례환자두로MRI상발현이상신호;병조주요위우대뇌백질,측뇌실、중뇌도수관화변지체주위급교뇌、연수,근거병조형태가장기분위산재불규칙형(13/17례)、융합형(3/17례)、다발성경화양(1/17례),이산재불규칙형병조다견;5례반유뇌간병변자주요림상표현위:기수、구토、복시、시물선전,기타뇌백질구손해무림상증상,11례뇌손해환자혈청NMO-IgG항체양성.결론 약반수NMO반유뇌손해,병조다분포우대뇌백질、뇌실방、뇌간등수통도단백4(AQP4)고표체구,림상표현여병조대소무관이여병조부위유관:뇌간수루자역반유상응림상표현,대뇌백질병변무림상표현.혈청NMO-IgG항체검측유조우감별반유뇌병조적NMO화다발성경화.
Objective To investigate the feature brain damage and clinical manifestations in neuromyelitis optica (NMO) patients; To investigate the relationship between serum NMO-IgG antibody and NMO brain damage. Methods Clinical data of 37 NMO patients and their head and spinal cord MRI by 1.5T superconducting MR scanner, were analyzed; serum NMO-IgG antibody were measured by immunofluorescence. Results 17 cases were found to have abnormal signals on MRI, which were mainly in the white matter, pons, medulla, ventricle, aqueduct, and around the corpus callosum; According to pathological changes, brain damage can be divided into scattered irregularity (13 cases), fusion (3 cases),multiple sclerosis-like (1 case) ,with scattered irregularity more common,5 cases had clinical manifestations of brain damage: somnolence, vomiting, diplopia, visual rotation, 11 cases patients with brainstem damage show positive serum NMO-IgG antibodies. Conclusions Brain damage can be seen in half of NMO patients, they often located in the high expression area of AQP4: brain white matter, periventricular,brainstem and so on. Clinical symptoms has nothing to do with the size of lesions but the location, they often occur when brainstem was involved. Serum NMO-IgG is helpful in differentiating NMO with brain damage and MS.